Weight to go!-Glucagon-like peptide 1 receptor agonists in liver transplant recipients

Division of Gastroenterology and Hepatology, Michigan Medicine, University of Michigan Disclosure:1. atricia P. Bloom is the guarantor of this article. 2.Roles, a.Writing: Abhishek Shenoy, Patricia P. Bloom, b.Critical revision: Abhishek Shenoy, Patricia P. Bloom Funding: None Patricia P. Bloom consults for Nexilico and received grants from Vedanta Biosciences. Abbreviations: AOM, anti-obesity medications; GLP-1RA, glucagon-like peptide 1 receptor agonist; LTR, liver transplant recipient; MASH, metabolic dysfunction–associated steatohepatitis; MASLD, metabolic dysfunction–associated steatotic liver disease; TBWL, total body weight loss. COI: Abhishek Shenoy reports no conflicts of interest related to this work. Correspondence Patricia Bloom, MD, 1500 E Medical Center Dr. 3912 Taubman Center, Box 5362, Ann Arbor, MI 48109. Email: [email protected]